沈祖堯 教授 及 卞兆祥 博士

謝達之 醫生

項目背景

IBS is a very common functional gastrointestinal disorder characterized by recurrent abdominal pain with disturbance in bowel habit, with high prevalence of IBS in Hong Kong and elsewhere. As a common disorder, there is no effective remedy in conventional medicine.  A Chinese herbal formulation was tested in double-blind and placebo-controlled trial alongside scoring of improvements over quality of life by patients. The change in brain activation was also evaluated using functional magnetic resonance imaging (fMRI); technique.

產品特徵

• A Chinese herbal formulation (patents pending; PRC) with indication of efficacy in Chinese male and female patients with more than 3 years history of IBS.
• An Integrated Research Clinic involving western clinicians and Chinese medicine practitioners for diagnosis and clinical research (using a validated questionnaire for quality of life assessment)
• Established rat research model for IBS

知識產權與專利

• Small-scale efficacy studies with both clinical and animal studies
• To enter pre-clinical development for filing IND in China and Hong Kong
• Patent pending: PRC 

相關刊物

• JCM-16021 – 腸易激綜合症

• 朱志賢先生
  電話: (852) 3551 7309 / 傳真: (852) 3551 7333
• 電郵: raymondchu@hkjcicm.org